Prothrombin fragment F1 + 2 concentrations for monitoring anticoagulation therapy with heparin
- 1 January 1993
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 38 (1) , 57-61
- https://doi.org/10.1016/0167-5273(93)90204-t
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- HeparinNew England Journal of Medicine, 1991
- Determination of Human Prothrombin Activation Fragment 1+2 in Plasma with an Antibody against a Synthetic PeptideThrombosis and Haemostasis, 1991
- Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor XaBiochemical Journal, 1989
- The Mode of Action of Heparin in PlasmaThrombosis and Haemostasis, 1988
- Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses.Journal of Clinical Investigation, 1987
- The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparinBiochemical Journal, 1987
- Prothrombin fragment 1 X 2 X 3, a major product of prothrombin activation in human plasma.Journal of Biological Chemistry, 1986